MM
3M Company
MMM · Industrials
Company brief
MM
MMMIndustrials$62.8B

3M Company

Diversified technology company with manufacturing operations across industrial, healthcare, safety, electronics, and consumer markets

Moat score
88/100
13F status
Tracking pending
Main Metrics

Beginner valuation check

Price
$149
Next earnings
Data pending

Data pending from FMP or Finnhub.

1Y Performance
-1.7%

Negative price performance shows recent market sentiment, not a full investment thesis.

Forward P/E
15.9x

Forward P/E around 15.9x means investors pay about $15.9 for each expected $1 of future profit per share, usually the next 12 months or next fiscal year. It is a forecast, not a fact.

P/E
27.4x

A P/E around 27.4x means investors pay about $27.4 for each $1 the company earned per share over the last 12 months, usually the last four quarterly reports.

EPS
$5.18
Market Cap
$76.3B
Forward P/E is the cleanest beginner valuation anchor here; compare it with growth and recent performance.

Source: market data index. As of May 21, 2026. P/E can be unavailable or misleading when earnings are negative.

Scenario Framework

Bull / Neutral / Bear

Neutral Case

MMM continues to trade on the quality of its diversified manufacturing base, with forward P/E as the main valuation reference and no 13F confirmation yet.

Watch signal

Forward P/E around 15.9x stays in line with the company’s growth and business quality.

What you own

3M Company is exposure to industrials operating model with high switching costs and 112% net revenue retention.

Base thesis

70+ years of proprietary chemical formulation data creates unassailable R&D moat

Main risk

The main question is whether the company can keep customer value compounding without margin pressure eroding the moat.

How to inspect it

Pro access unlocks the workflow simulator for this company brief.

Simulator coverage pending

This ticker has a company brief, but richer workflow modules have not been built yet.

Investor Snapshot
88Moat Score
Net Revenue Retention112%
Retention RiskLow
AI Disruption RiskMedium
Switching CostsHigh
13F Ownership
Tracking pending

No SEC-backed 13F rows are matched for this ticker yet. We do not fabricate ownership rows.

Investment Thesis
  • 70+ years of proprietary chemical formulation data creates unassailable R&D moat
  • Manufacturing processes deeply embedded in customer production lines increase switching costs
  • Regulatory approvals in healthcare/safety create 2-5 year replacement cycles
  • Geographic diversification across 70+ countries provides recession resilience
  • 15,000+ active patents with continuous innovation pipeline
  • AI enhances but cannot replace core materials science expertise and manufacturing know-how